Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia

被引:28
|
作者
Achtyes, Eric [1 ,2 ]
Simmons, Adam [3 ]
Skabeev, Anna [3 ]
Levy, Nikki [3 ]
Jiang, Ying [3 ]
Marcy, Patricia [4 ]
Weiden, Peter J. [3 ]
机构
[1] Cherry Hlth, Grand Rapids, MI USA
[2] Michigan State Univ, Coll Human Med, Grand Rapids, MI 49503 USA
[3] Alkermes Inc, Waltham, MA USA
[4] Northwell Hlth Syst, Vanguard Res Grp, Manhasset, NY USA
来源
BMC PSYCHIATRY | 2018年 / 18卷
关键词
Adherence; Antipsychotics; Weight; Side effects; PSYCHIATRY WFSBP GUIDELINES; BIOLOGICAL TREATMENT; ANTIPSYCHOTIC-DRUGS; REPORTED OUTCOMES; WORLD FEDERATION; UPDATE; 2012; MANAGEMENT; SOCIETIES;
D O I
10.1186/s12888-018-1856-y
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Despite the availability of numerous antipsychotic medications, many patients with schizophrenia continue to experience side effects that contribute to the overall burden of the illness. The present survey of patients with schizophrenia and schizoaffective disorder aimed to assess patient attitudes toward antipsychotic treatment, and understand key factors about willingness to try a new medication. Methods: A cross-sectional survey was administered to 250 patients with a primary clinical diagnosis of a schizophrenia spectrum disorder across five outpatient clinics in the United States. The survey included self-reported gender, age, weight, and height, and questions about the importance of efficacy and side effects on the decision to take a prescribed antipsychotic medication. Results: Patients rated efficacy and side effects as important attributes of antipsychotic treatment, with 93.6% and 83.6% of patients listing these as "very" or the "most" important factors in taking prescribed medication. A total of 87.6% of respondents identified the ability to think more clearly as an important property of their medication. Patients identified weight gain, physical restlessness, and somnolence as important side effects of current treatments ("very" or "most" important by 61.6%, 60.8%, and 58.8%, respectively). When asked about willingness to change antipsychotic medication, anticipated weight gain had a negative influence on willingness to try the new treatment, with 22.0% declining to try a medication that would lead to weight gain of 2.7-4.5 kg (6-10 lb), 34.0% declining for anticipated weight gain of 5.0-9.1 kg (11-20 lb), and 52.4% declining for anticipated weight gain greater than 9 kg (20 lbs). Conclusion: Patients living with schizophrenia spectrum disorders are influenced by many factors when considering whether to take their medication, including efficacy and side effects. It is important for clinicians to assess specific patient concerns to develop a comprehensive treatment plan that maximizes adherence to the prescribed therapy.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Antipsychotic Drug Treatment for Patients with Schizophrenia: Theoretical Background, Clinical Considerations and Patient Preferences
    Nielsen, Rene Ernst
    Nielsen, Jimmi
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1053 - 1068
  • [42] The effect of anticholinergic burden on cognitive and daily living functions in patients with schizophrenia
    Kim, Sung-Jin
    Jung, Doun
    Shim, Joo-Cheol
    Moon, Jung-Joon
    Jeon, Dong-Wook
    Kim, You-Na
    Seo, Young-Soo
    Jung, Sung-Soo
    Seo, Beom-Joo
    Kim, Jeong-Eun
    ASIAN JOURNAL OF PSYCHIATRY, 2019, 46 : 111 - 117
  • [43] The effect of anticholinergic burden on cognitive and daily living function in patients with schizophrenia
    Park, S. Y.
    Kim, S. J.
    Jung, D. U.
    Moon, J. J.
    Jeon, D. W.
    Jung, S. S.
    Kim, J. E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S267 - S268
  • [44] The effect of a physical activity programme on improving mood profile of patients with schizophrenia
    Maggouritsa, Georgia
    Kokaridas, Dimitrios
    Theodorakis, Ioannis
    Patsiaouras, Asterios
    Mouzas, Odysseas
    Dimitrakopoulos, Stefanos
    Diggelidis, Nikolaos
    INTERNATIONAL JOURNAL OF SPORT AND EXERCISE PSYCHOLOGY, 2014, 12 (03) : 273 - 284
  • [45] IMPACT OF SIDE EFFECTS DUE TO SECOND-GENERATION ANTIPSYCHOTICS ON THE FUNCTIONING OF PATIENTS WITH SCHIZOPHRENIA: AN OBSERVATIONAL, PATIENT CENTERED, WEB SURVEY
    Tandon, Rajiv
    Weiss, Catherine
    Lenderking, William
    Cooper, Owen
    Shalhoub, Huda
    Kleinman, Leah
    Chen, Jun
    Hartry, Ann
    Green, Mallik
    Meehan, Stine R.
    Douvold, Laetitia Bouerat
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S241 - S241
  • [46] DIFFERENTIAL SIDE-EFFECT PROFILE OF TRIAZOLAM VERSUS FLURAZEPAM IN ELDERLY PATIENTS UNDERGOING REHABILITATION THERAPY
    WOO, E
    PROULX, SM
    GREENBLATT, DJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (02): : 168 - 173
  • [47] Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients:: A comparison of efficacy, side-effect profile, and cost
    Abali, Huseyin
    Celik, Ismail
    CANCER INVESTIGATION, 2007, 25 (03) : 135 - 139
  • [48] FUNCTIONAL CHOREA DIAGNOSED IN A PATIENT WITH SCHIZOPHRENIA TREATED WITH PALIPERIDONE: EXTRAPYRAMIDAL SIDE EFFECT OR FUNCTIONAL?
    Kucukdagli, F. Erdogan
    Saltoglu, T.
    Karadag, Y. Sucullu
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 67 - 67
  • [49] Clozapine Triggering Cecal Volvulus in a Patient With Malrotation and Schizophrenia: Side Effect That Needs Emphasis
    Aneja, Jitender
    Varshney, Vaibhav
    Sreesanth, K. S.
    Singhai, Kartik
    Yadav, Taruna
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (05)
  • [50] THE BEST THERAPY FOR HELICOBACTER-PYLORI INFECTION - SHOULD EFFICACY OR SIDE-EFFECT PROFILE DETERMINE OUR CHOICE
    DEBOER, WA
    TYTGAT, GNJ
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1995, 30 (05) : 401 - 407